期刊文献+

急性心肌梗死和稳定型心绞痛血小板GPⅡb、GPⅢa动态变化的比较研究 被引量:5

Dynamic Changes of Platelet Membrane Glucoprotein Ⅱb and GPⅢa Contents in Stable Angina Pectoris and AMI
下载PDF
导出
摘要 目的:观察急性心肌梗死(AMI)和稳定型心绞痛(SAP)血液中血小板表面糖蛋白GPⅡb和GPⅢa的动态变化,探讨急性心肌缺血前、后血小板的活性。方法:61例住院的心病患者,其中AMI32例,SAP29例,采用竞争性酶联免疫方法比较AMI及SAP患者发病后24h,第2天、第3天、1财2周时血中血汀反GPⅡb和GPⅢa的含量动态变化,并进行统计学分析。 To observe dynamic changes of platelet membrane glucoprotein(GP) Ⅱb and GPⅢa in blood circulation in acute myocardial infarction(AMI)and stable angina pectoris(SAP)of coronary heart disease, in order to investigate platelet activation before and after acute iechemic onset. Methods: Platelet membrane GPⅡb and GPⅢa were examined for 6lh os- pitalized cases with AMI or SAP at 24 hours, second day, third day,first week and second week after the attacks,using EIA and statistical analyses. Results:Platelet GPⅡb and GPⅢa contents of SAP group at 24 h, second day, third day, 1st,2nd week[6.86 ± 2.74/5 .94 ± 1 .96,6.25 ± 1 .85/5 .61 ± 1 .45,6.74 ± 2.67/6.07 ± 1 .99,5 .96 ± 2.35/5 .76 ± 1 .59,7.56 ± 2.72/7. 17 ± 2.45 (× 10~4 /Pt respectively)]were higher than those of control group[3 .91 ± 0.36/4 .53 ±0.51 (× 10~4 / Pt) ],there was significant between-group difference, it showed that platelets were activated. GPⅡb and GPⅢa of AMI group at 24 h, second, third day, lst, 2nd week[8.38 2.38/7.62 ± 1 .69, 8.39 ± 2.55/7.64 ± 1 .86, 8.32 ± 2 .38/ 7.29 ± 1 .45,7.40 ± 2. 10/6.73 ± 1 .46, 6.53 ± 2. 18/6.36 ± 1 .29(x 10~4 /Pt)]were higher than the control group(P< 0. 01 ), there was significant between-group difference. GPⅡb and GPⅢa of AMI group had peak time at least within 3 days and a negative correlation with time. Comparison of GPⅡb and GPⅢa of AMI group with SAP group in first 3 days showed significant differences,but there were no significant differences between these tow groups at lst weed and 2nd week. Con- clusions:Platelets activation at AMI persisted 3 days peak time at least, it showed that GPⅡb and GPⅢa took part in the attack of AMI. So it is necessary to use the platelet GPⅡb and GPⅢa inhibitor in AMI, especially within first 3 days.
机构地区 天津市公安医院
出处 《天津医药》 CAS 1999年第11期646-648,共3页 Tianjin Medical Journal
关键词 心肌梗塞 心绞痛 血小板 膜糖蛋白类 血小板活化 myocardial infarction acute disease angina pectoris blood platelets membrane glycoproteins plate- let activation
  • 相关文献

参考文献3

二级参考文献1

共引文献13

同被引文献46

  • 1孙燕淑,祁芸芸,袁家颖.房颤患者血小板膜糖蛋白Ⅱ_b/Ⅲ_a受体的变化及意义[J].中国临床医学,2001,8(1):60-61. 被引量:7
  • 2陈燕,陈慧.基质金属蛋白酶-9与易损斑块[J].心血管康复医学杂志,2007,16(1):96-98. 被引量:15
  • 3Harrington RA. Overview of clinical trials of glycoprote in Ⅱ b/Ⅲa inhibitors in acute coronary syndromes. Am Heart J, 1999; 138 (4Pt 2) :276-286.
  • 4Wu kk. Genetic markers: gene involved in thrombosis. J Cardiovascrisk, 1997:4:347.
  • 5Murata M, Kawano K, Matsubara Y, et al. Genetic polymorphisms and risk of coronary artery disease. Semin Thromb Hemost, 1998;24 : 245.
  • 6Gensini GF, Comeglio M, Colella A, et al. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J, 1998; 19(supplA) :A53.
  • 7Weiss EJ, Bray PF, Tayback M, et al. Apolymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. New Engl J Med, 1996;334:1090.
  • 8Coller BS. Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein Ⅱ b- Ⅲ a receptor in an experimental animal model. Blood, 1996;68:783-785.
  • 9Philips DR, Charo IF, Parise LV, et al. The platelet membrane glycoprotein Ⅱ b/Ⅲ a complex. Blood, 1998;71:831-843.
  • 10Ridker PM, Hennekens CH, Sclunitzs C,et al. pIA2polymorphism of glycoprotein ma and risk of myocardial infarction, stroke and venous thrombosis. Lancet, 1997;349:385.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部